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This paper reviews the transmission modes of Trypanosoma evansi. Its worldwide distribution is attributed to mechanical
transmission. While the role of tabanids is clear, we raise questions on the relative role of Haematobia sp. and the possible role
of Stomoxys sp. in delayed transmission. A review of the available trypanocidal drugs and their efficacy in various host species is
useful for understanding how they interact in disease epidemiology, which is complex. Although there are similarities with other
mechanically transmitted trypanosomes, T. evansi has a more complex epidemiology due to the diversity of its hosts and vectors.
The impact of clinical and subclinical disease is difficult to establish. Amodel was developed for buffaloes in the Philippines, which
could be transferred to other places and livestock systems. Since Trypanosoma evansi was reported in humans, further research
is required to investigate its zoonotic potential. Surra remains a potentially emerging disease that is a threat to Australia, Spain,
and France. A number of questions about the disease have yet to be resolved. This brief review of the basic knowledge of T. evansi
suggests that there is renewed interest in the parasite, which is spreading and has a major economic impact.
1. Introduction
Of all the pathogenic trypanosomes, Trypanosoma evansi
has the widest host range and geographical distribution,
worldwide. By comparison, its ancestor Trypanosoma brucei
had a limited geographical distribution. This “evolution” is
largely attributed to the new modes of transmission acquired
by the parasite when it lost some of its genetic material
allowing to implement the cyclical transmission in tsetse flies.
Trypanosoma evansi has a huge range of hosts receptive
and susceptible to the infection, in which it exhibits highly
variable clinical effects, depending on the host and the
geographical area. These characteristics make surra not only
a multispecies but also a polymorphic disease. In fact, it
may even constitute a complex of diseases induced by a
“group” of parasites named Trypanosoma evansi (or a group
of sub species named Trypanosoma brucei evansi) [1]. In
this review, we focus on the transmission of the parasite, its
geographically variable epidemiology, the use of trypanocides
to control infection, the difficulty of evaluating its impact,
and lastly, the parasite’s zoonotic potential. In conclusion,
we recommend undertaking additional studies to further
understanding of the disease epidemiology and dynamics
in order to improve control. Every effort should be made
to avoid the continuous geographical spread of the disease,
including its circulation, emergence, and reemergence.
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2. Transmission
Trypanosoma evansimay have multiple origins, geographical
locations, hosts, and clinical features. In addition, it has
multiple and complex means of transmission, which vary in
terms of relative significance depending on the hosts and the
geographical area. Indeed, T. evansi is transmitted in several
ways, via biting insects, sucking insects, and vampire bats;
transmission can also be vertical, horizontal, iatrogenic, and
per-oral, with various epidemiological significances, depend-
ing on the season, the location, and host species. Similarly,
leeches may transmit trypanosomes, and their potential for
transmission of T. evansi should be explored, especially for
buffalo leech (Hirudinaria manillensis) in Asia.
2.1. Mechanical Transmission. Mechanical transmission by
biting insects is the most important mode of transmission
of T. evansi in camels, as well as in livestock and other large
animals generally. People have suspected this to be the case
for a long time: for example, in Algeria, El debab (means “fly”)
or in India people thought that horseflies played a role in
surra, known as “makhi ki bimari” (horsefly disease) in the
Punjab region [2].
Mechanical transmission is a nonspecific process, which
can take place when a biting insect initiates a blood meal
on an infected host, starts to feed on infected blood, is
interrupted (by defensive movements of the host, e.g.), flies
off from the infected host, and lands on another animal to
begin its blood meal again. When the insect first attempts to
feed on blood, its mouthparts can contain a small amount of
blood via capillary strength, estimated at 1–12 nl in tabanids
and 0.03 nl in Stomoxys [3]. The residual blood may be
partially inoculated into another animal during the early
stage of the next attempt to bite, when the insect inoculates
a small amount of saliva (necessary for its anticoagulant
properties) prior to sucking the blood of the second host
[3–6]. A mathematical model has recently been developed;
for cattle carrying a mean burden of 20–30 tabanids per
head, the model indicated that the probability of transmis-
sion becomes significant when parasitaemia is above 106
trypanosomes/mL [4]. Thus, in camels, which may exhibit
very high parasitaemia (>108 T. evansi/mL), tabanids and
Stomoxys may be responsible for the transmission of T.
evansi; possibly, Haematobia (Figure 1(e)) and hippobosques
(Figure 1(f)) might act as well.
In biting insects, trypanosomes do not generally survive
for very long. For example, their survival was estimated at
30minwithT. vivax in tabanids and even shorter in Stomoxys
sp. [7]. Experimental research shows that the transmission
is efficient when there is a short time lapse between two
interrupted blood meals, that is, less than 30 minutes [8, 9].
Immediate mechanical transmission of this type can only
occur in a group of animals (e.g., intraherd transmission). It
leads to a high incidence of disease in a given herd. However,
it may occur between herds of the same species (camels) or
of different species (camels and goats, e.g.) at a water point.
Transmission can also occur between wild and domestic
herbivores, such as deer or capybaras when they graze with
horses, cattle, or buffalo. This occurs in extensive breeding
conditions in Brazil [10], for example.
An alternative to the immediate transmission of try-
panosomes occurs when blood from the insect’s gut or crop is
regurgitated in the early stages of the blood feeding process.
This could enable delayed transmission because parasites can
survive in the stomach for 5–7 h in the case of T. vivax in
tabanids [7]. Trypanosomes could survive for even longer
periods in the crop of Stomoxys [11], where the absence of
digestive secretion provides a more friendly environment.
In experimental conditions of interrupted feeds, successful
transmissions were obtained after 4 hours with Tabanus
nemocallosus, 8 h with T. rubidus (Figure 1(a)), 24 h with
T. albimedius, and up to 72 h with T. striatus (Figure 1(b)).
The probability of success decreases drastically from 1 : 10
after 30min to 1 : 1,000 after 6 hours [2]. However, tabanids
are persistent feeders in natural conditions and, therefore,
these results for delayed transmission would not apply. Once
tabanids have initiated a bloodmeal, theymake every attempt
to complete it (even if it is interrupted), within a very short
period of time; that is, they do not wait 4–72 h. Once satisfied,
tabanids do not look for a host before 5–7 days have elapsed.
T. evansi cannot survive that long; therefore, the probability
of delayed transmission by tabanids is very low [6].
On the contrary, in early experiments with Stomoxys, it
was shown that T. evansi could be transmitted 48 h after an
infective bloodmeal [12].This is unlikely to be due to residual
blood on the mouthparts (survival was proven to be limited
to 30min in Stomoxys), but rather to the regurgitation of
infected blood from the crop. However, it was demonstrated
that Stomoxys may naturally have two blood meals in the
same day or at 24-hour intervals [13]. This observation
potentially has a very high epidemiological impact because a
“split blood meal” would allow transmission over long time
intervals. These intervals may range from a few hours to a
few days.Thus, transmission may occur between herds in the
same place (stationary insects) or between herds attacked by
the samemobile insects. However, this experimental research
needs to be confirmed. “Delayed mechanical transmission”
might lead to the concept of “infective area,” such as a water
point, where an infected herd could infect Stomoxys at a
given time, which in turn would infect healthy animals (4–48
hours later), in the absence of contact between infected and
uninfected herds.
Mechanical transmission of T. evansi is thought to be
essentially due to tabanids and Stomoxys. However, Hip-
poboscids were previously suspected, especially in camels
and horses (Hippobosca equina and H. camelina) [2]. Other
insects, such as Culicidae, Ceratopogonidaemay also have an
important role in transmission in particular local conditions.
Experimental transmission of T. evansi has been successful
with Aedes aegypti, Ae. Argenteus, and Anopheles fuliginosus.
However, the epidemiological significance has not been
demonstrated (Kesler 1927 and Nieschulz 1928 quoted by
Gill, [2]). It is not possible to establish an exhaustive list of
the potential mechanical vectors of T. evansi. However, the
most important are the largest and most abundant biting
insects.Themathematic model of trypanosome transmission
by tabanids developed by Desquesnes et al. [4] has shown
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(a) Tabanus rubidus (18–25mm) (b) Tabanus striatus (13–18mm)
(c) Haematopota sp. (8–15mm) (d) Chrysops dispar (9–16mm)
(e) Stomoxys sp. & Haematobia sp. (5–9 & 2.5–4mm) (f) Hippobosca sp. (9–13mm)
Figure 1: Some of the potential vectors of Trypanosoma evansi in Thailand.
that the incidence of transmission is directly linked to
parasitaemia and the number of biting insects around the
hosts.The transmission of the infection is related to a number
of subparameters, including the size (and morphology) of
the biting insect (volume of blood potentially transferred
from one host to another) and the insect density. Thus, a
high number of “small Stomoxys” can be as efficient as a low
number of “large tabanids.”
Gill [2] mentioned that successful experimental trans-
missions have been reported in no less than 29 Tabanus
sp., including Tabanus rubidus, T. ditaeniatus, T. immanis, T.
rufiventris, T. malayensis, T. optatus, T. ceylonicus, T. partitus,
T. striatus, and T. tenens. He also reported several successful
transmissions with Haematopota spp. (Figure 1(c)), H. cin-
gulata, H. truncate, H. irrorata, H. pungens, Chrysops dispar
(Figure 1(d)), C. flaviventris, C. fasciata, and even the lous
Haematopinus tuberculatus (Mitzmain, 1913, quoted by Gill,
[2]). Lyperosia minuta was also suspected on the basis of
field observations, although experimental transmissionswere
unsuccessful [2]. Several demonstrations in experimental
conditions were also reported for Stomoxys (Figure 1(e)) by
Gill [2], with Stomoxys calcitrans and by other authors for S.
niger, S. varipes, S. taeniatus, S. pallidus, and Haematobosca
squalida [8, 9].The role ofHaematobia sp., the smallest of the
Stomoxyine flies (2–4mm), has never been demonstrated,
probably due to its small size, which makes it inconvenient
for laboratory experiments. However, it should be studied
because the density of Haematobia observed in the field is
frequently very high (Figures 1(e) and 2). In otherwords, their
role may not be as negligible as their size!
Lastly, the potential role of reduviid bugs as mechanical
vectors was demonstrated experimentally [14]. However,
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(a) (b)
Figure 2: Potential role ofHaematobia sp. (a) Common level of infestation byHaematobia sp. on the back of a cattle,Thailand (one Stomoxys
sp. also visible); (b) Haematobia species (2.5–4mm).
bugs do not move quickly from one host to another. There-
fore, when they are infected when they first bite a host, they
may not be able to move to another host in time to transmit
the infection through another bite. Alternatively, infected
bugsmay be ingested by a host and, thus, transmit the parasite
by the per-oral route.This occurswithT.melophagium, which
is a stercorarian parasite transmitted to sheepwhen they chew
the cyclical vector (Melophagus ovinus) [15].
Sucking flies can also transmit trypanosomes, via simple
contamination of a wound, which may even be the feeding
site of a biting insect. Musca sorbens was proven to transmit
Trypanosoma brucei rhodesiense [16]. The same could also
apply to T. evansi and was reported with Musca crassirostris
[2].
Sucking flies may also increase the risk of mechanical
transmission by other biting flies. In Thailand, some sucking
flies on cattle have been observed escorting Stomoxys and
pushing them away immediately in order to suck the blood
at the biting site (M. Desquesnes, unpublished observation).
By doing so, the sucking flies increase the risk of mechanical
transmission by Stomoxys (by increasing the interrupted
feeding).They also contaminate their ownmouthparts for the
potential transmission of a parasite to a neighbouring host.
This phenomenon should be called “transfection” rather than
“transmission.”
2.2. Other Means of Transmission. Besides vector transmis-
sions and the contamination of a wound, iatrogenic transmis-
sion caused by the use of nonsterile surgical instruments or
needles may be of importance, especially during vaccination
campaigns and mass treatments that could spread disease
[17].
Sexual transmission or transmission from dam to calf
or foal could occur in particular cases, when mucosae are
altered or in cases of very close contact (licking) with
parasitised secretions (mucus, lacrymation, etc.). This may
be responsible for occasional direct horizontal transmission,
although the real impact has not been estimated.
Transplacental infections have been described in T.
equiperdum and T. brucei [18, 19]. Vertical transmission of
T. evansi has also been demonstrated in several instances,
as shown in a review on transplacental transmission of try-
panosomes [20]. Indeed, in several cases of abortion in cattle
and buffalo, the foetus was proven to be infected, directly or
via mouse inoculation. Although vertical transmission may
have a low impact on the incidence of the infection, it may
be an important factor in the long-term maintenance of an
infection in a herd or a given geographical area. It may also
lead to the birth of healthy carriers that constitute a future
reservoir for the multiplication of the parasite. Multiplication
may occur under pressure from stress after a long period of
subclinical infection.Therefore, vertical transmission may be
the source of long-term resurgences.
Trypanozoon, especially T. evansi, may be transmitted
by per-oral contamination. This mechanism could obviously
occur quite easily when the oral mucosae are damaged. This
may be frequent when carnivores eat infected prey. Dogs and
cats living in the vicinity of slaughterhouses could be infected
by eating fresh meat, blood, offal, or bones. Hunting dogs
and wild carnivores could be contaminated in this way. The
observation of circus tigers infected by T. evansi also suggests
that infection is most probably due to eating infected meat
[21]. Thus, the presence of T. evansi in French Guiana was
revealed by the observation of a single case in a hunting dog
[22], which demonstrates the importance of the role of the
dog as a sentinel for surra [23].
Carnivores are not the only animals that are infected by
the per-oral route. Under experimental conditions, it was
demonstrated that the penetration of trypomastigote forms
of the parasite can occur through the normal oral mucosae,
in which T. brucei was able to multiply [24]. With T. evansi,
it was shown that dogs and mice fed with meat and blood
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were infected [25], as well as rats fed on blood [26, 27].
However, the parasite is unable to survive in the stomach
of carnivores and rodents because of the pH conditions.
Therefore, in these hosts, the penetration of the parasite
inevitably occurs through the oral mucosae. Conversely, the
parasite can survive and pass through the oral mucosa, the
oesophagus, and the stomach mucosa of vampire bats [28].
Other modes of transmission could be investigated, such
as leeches, ticks (as carriers), and other blood feeders.
2.3. Biological Vector: Vampire Bats. Transmission by the
vampire bat is a new biological system that has been estab-
lished in Latin America, thanks to the conquistadores who
introduced both T. evansi and its hosts on the subcontinent
[15]. Vampire bats are infected by the oral route when they
leak blood from an infected prey (most often horses or
cattle). As a host of T. evansi, bats may develop clinical
symptoms and die during the initial phase of the disease
(1 month). However, in the case of bats that survive, the
parasite multiplies in the blood and is then found in the
saliva of chronically infected bats or in bats that do not show
any clinical symptoms. Later, infected bats can contaminate
their congeners by biting, thus acting as true reservoir hosts.
They can also contaminate livestock, acting as permanent
vectors, capable of contaminating their host for a long period
of time. Lastly, in the case of bats, the trypanosome may be
transmitted from biter to bitten or vice versa [23]. Since the
vampire bats can contaminate each other, a vampire colony
canmaintainT. evansi in the absence of themain host (horse),
which makes them a true reservoir of the parasite. When
feeding on horses or cattle, vampire bats are true vectors, in
as much as they initiate infection that biting insects can then
spread to other susceptible animals [15, 28, 29]. The vampire
batDesmodus rotundus acts as a host, reservoir, and biological
vector of the parasite.
The differentmodes of transmission presented abovemay
have variable importance depending on the host and epi-
demiological cycle. For example, biting insect transmission is
very important in livestock or large animals more generally,
vampire bat transmission is important in horses and cattle,
though only in Latin America, and per-oral transmission
is predominant in carnivores, vampire bats, and probably
rodents. However, important data is missing in terms of our
current knowledge, including data on the link between large
animals andwild rodents, how rodents are contaminated, and
the potential back infection from rodents to livestock or from
carnivores to herbivores.This will be further discussed under
the epidemiology section.
3. Control
Disease control is generally presented last, following the
description of epidemiology. However, we decided to discuss
disease control first because trypanocide use is now part
of regular livestock management in all areas endemic for
trypanosomoses. In other words, disease control has become
part of disease epidemiology.Thus, it can only be understood
if we take into consideration the continuous and cosmopoli-
tan use of trypanocide drugs for livestock.
The control of a vectorial disease is classically divided into
two sections: pathogen control and vector control. There are
also various alternative means of controlling transmission,
which can be combined as “means to prevent the infection.”
In the case of surra, in the absence of a vaccine against
trypanosomes (due to a large repertoire of variable surface
antigens), disease control is principally based on the use of
trypanocides andpreventivemanagementmethods to protect
animals from infection.
3.1. Chemical Control of Parasites. As a blood parasite, T.
evansi can be killed by injecting various trypanocidal drugs,
providing that concentration of the chemical in the serum is
lethal for the parasite. However, treatment might fail in the
case of extravascular invasion or chemoresistance.
Trypanocides can be divided into two categories. The
“curative drugs” are used for treatment and have a short-term
effect.They can kill the parasites, although they do not always
eliminate 100% of them. The “curative/preventive drugs” are
used for chemoprophylaxis. They not only kill parasites but
also prevent any new infection or new circulation of parasites,
due to the remanence of a sustainable curative dose in the
serum of animals under chemoprophylaxis.
3.1.1. Curative and Chemoprophylactic Drugs. Curative drugs
aim to eliminate parasites from a sick animal. A drug could be
regarded as “curative” when the dose used is able to eliminate
all parasites. The most widely used curative trypanocide
against surra is diminazene aceturate. However, other drugs
can be used, such as isometamidium chloride (both curative
and preventive), cymelarsan (so far, only recommended for
curative treatment of camels), suramin, and quinapyramine
(curative and/or preventive) [30].
Diminazene aceturate (DA) is an aromatic diamidine
used to control babesia and trypanosome infection in rumi-
nants. A curative dose of DA is administered via intra-
muscular injection to obtain a high concentration of the
chemical in the circulating blood. The withdrawal period for
the consumption of produce fromcattle injectedwithDA is 21
days for meat and 3 days for milk [31]. However, the chemical
dose in the serum actually suggests a longer withdrawal
period of 30 and 21 days for meat and milk, respectively
[32]. The dose recommended for the treatment of infections
due to parasites belonging to the Trypanozoon subgenus is
7mg/kg bodyweight (bw) of DA, via intramuscular injection.
The reality in the field often reveals that a dose of 3.5mg/kg
bw is used to control surra.This could be for various reasons,
including ignorance of the right dose or concern to save
money by reducing the cost of treatment. Use of the “wrong”
dose is based on the recommended dose for the treatment of
infections by two otherAfricanTrypanosoma species:T. vivax
and T. congolense. Diminazene aceturate is recommended
in ruminants. Its use in horses and dogs is limited due to
poor efficacy and tolerance in these species. Diminazene
aceturate has been used for a long time. Consequently,
trypanosomes have developed chemoresistance inmost parts
of the world [23, 31]. Using 3.5mg/kg bw to control T. evansi
can be considered as underdosing, as is often the case in
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Thailand and more generally in South East Asia. This dose
can be regarded as a “premunition treatment,” when the host
remains infected, (although clinically cured), contrary to the
curative dose that eliminates all parasites. Such low dose
treatment can lead to the selection of chemoresistant strains.
In Thailand, for example, the inefficiency of DA in bovines,
horses, pigs, and elephants has frequently been reported [33–
36].
Isometamidium chloride (IMC) belongs to the phenan-
thridine family, as well as homidium chloride or bromide.
However, the latter are highly toxic because they are DNA
intercalating agents. Their mutagenic action was demon-
strated early on [37, 38]. Therefore, their use in the field
is not recommended. IMC is not known as a carcinogenic
agent. It can be used for curative (0.5mg/kg bw) and pre-
ventive (1mg/kg bw) treatment of trypanosome infections
in ruminants and horses, via intramuscular or subcutaneous
injection. Alternate use ofDAand IMCconstitutes a “sanative
pair,” whichmeans that once resistance develops to one of the
drugs, the other drug should be used to control the infection
[30]. The withdrawal period for the consumption of produce
in cattle injected with IMC is 23 days. However, it is obvious
that the chemical can circulate in the blood for up to 4-5
months after injection [39]. Consequently, a safe withdrawal
period should be much longer, from around 3 months (when
0.5mg/kg is injected) to 6months (when 1mg/kg is injected).
These withdrawal periods make IMC poorly adapted to beef
or dairy cattle. Horses have a limited tolerance to IMC [40],
although it remains an alternative to DA.
Melarsomine dihydrochloride (Cymelarsan) is the latest
trypanocide to be developed. It was first available for com-
mercial use in 1992. It is used to control surra in camels via
deep intramuscular injection at a dose rate of 0.25mg/kg bw
[23]. Evaluations conducted on other host species suggest
using rates of 0.25–0.5mg/kg bw in horses, 0.5mg/kg bw in
cattle, and 0.75mg/kg bw in buffaloes [41–43].However, tran-
sient side effects (nervous signs) were observed in buffaloes
treated with 0.75mg/kg bw (Dargantes et al., unpublished
data). Dogs have a satisfactory tolerance to the drug. It is
recommended for the treatment of heartworm (Dirofilaria
immitis) (Immiticide), at a dose of up to 2.5mg/kg bw (via
deep intralumbar injection). It can be used at a rate of 1-
2mg/kg bw against T. evansi infections. However, in the case
of nervous infections in horses and dogs, even high doses,
respectively, 0.5mg/kg bw and 2mg/kg bw, failed to cure the
animals [44, 45].
Suramin is an ureic component which was used in horses
and camels by intravenous injection. It was effective against
T. evansi infection, although it is no longer used.
Quinapyramine belongs to the group of aminoquinaldine
derivatives. Quinapyramine methyl-sulphate can be used to
treat the infection by subcutaneous injection at a dose of
5mg/kg bw. A more effective combination of quinapyramine
sulphate and quinapyramine chloride (Triquin) can be used
as a curative/preventive drug against T. evansi in horses and
camels, administered by subcutaneous injection at a dose of
8mg/kg bw. Local tolerance is sometimes low. However, the
drug is quite efficient and the chemoprophylactic effect can
last up to 4months [46]. In cattle, the use of quinapyramine is
not recommended because it may induce cross-resistance to
both DA and IMC [47]. Its use should be restricted to horses
and camels only.
3.1.2. The Use of Trypanocides in Various Host Species. Buf-
falo, cattle, and small ruminants infected by T. evansi can
be treated with DA (preferred drug) at a dose of 7mg/kg
bw by intramuscular injection. The withdrawal period for
meat consumption should be >30 days. In the case of strong
clinical signs, especially when parasitaemia is high, an initial
injection of 3.5mg/kg bw DA may be given to reduce the
parasitaemia and a second injection of 7mg/kg bw can be
given 5 days later to ensure that all the parasites are killed.
If the treatment is ineffective, the use of IMC is rec-
ommended at a dose of 0.5mg/kg (withdrawal period for
meat should be >90 days). Alternatively, the efficacy of
melarsomine hydrochloride was recently demonstrated (no
nervous signs were observed), at a dose of 0.5mg/kg bw
by deep intramuscular injection in cattle [45] and buffaloes
(Dargantes et al., unpublished data).
Horses, dogs, and cats can be treated with DA or IMC
despite being quite sensitive to the drugs. It is essential to
provide an adequate water supply to avoid a toxic effect on
the kidneys, which can be fatal. Similarly, in the case of
very high parasitaemia in cattle, half a dose of DA or IMC,
followed by a normal dose 5 days later can be administered.
Given that horses have a low tolerance to DA and IMC,
the normal recommended dose can also be split into two
subboosts (DA 2 × 3.5mg/kg and IMC 2 × 0.25mg/kg).
However, the intervals between the subboosts should not
be too long, otherwise the curative drug concentration in
the plasma will not be reached. In such cases, injecting
two subboosts with a 3–5-hour interval is recommended.
DA treatment is not efficient in the case of nervous infec-
tion. Results of DA or IMC treatment may be satisfying,
although chemoresistance is often observed, which limits the
effectiveness of treatment. As an alternative, the efficacy of
melarsomine dihydrochloride was evaluated in horses and
dogs. The treatment can clear the parasite from the blood.
However, in cases of nervous infection, it is inefficient and
may cause death in the patients [44, 45]. Another alternative
is the treatment of horses with quinapyramine sulphate
and chloride (curative and chemoprophylactic effect), which
provides durable protection to the animals. Nonetheless,
we do not know whether the infected animals that receive
such treatment are sterilised from the infection or whether
they can carry the parasite in extravascular foci, such as
joint fluids, cerebrospinal fluid, and aqueous humour of the
eye, as has been demonstrated in camels [48]. However,
if parasites do survive in an extravascular refuge and later
attempt to reinvade the blood, they would be killed on
reaching the blood given the chemoprophylactic drug’s long-
lasting action. In such conditions, keeping horses alive in
enzootic areas might require regular treatment with the
chemoprophylactic drug. Indeed, horse owners usually treat
their animals regularly, both in Latin America and South East
Asia [46]. In dogs, treatment with quinapyramine is poorly
documented, although drugs are available on the market
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(Interquin). Another alternative treatment for dogs could be
tried out, using 5–8 serial injections with DA at 3.5mg/kg
bw at a 2-3 week interval. In the absence of a trypanocide
capable of establishing curative treatment for dogs, this type
of strategy aims to enhance specific and protective immunity
against the parasite. This premunition status can be expected
within some months.
In camels, although a number of trypanocides have been
used (DA, IMC, suramin, quinapyramine, etc.), melarsomine
dihydrochloride is the ideal product (dose: 0.25mg/kg bw),
which can be increased up to 0.5mg/kg bw if fully curative
(sterilising) treatment is required for international trading. In
enzootic areas, a dose of 3.5mg/kg of DA can also be used.
However, it can induce severe side effects and might not be
sufficient to clear all parasites from the camel.
In pigs, little information is available on the control
practices used for African trypanosomes. Quinapyramine
may be used, as well as DA, though the latter appears to be of
limited efficacy [36]. IMC and melarsomine dihydrochloride
could also be used. However, experimental evaluations are
necessary to validate the treatment protocols.
In Asian elephants, several attempts have been made
with DA. Lower doses, such as 5mg/kg bw, resulted in
relapses [49, 50], while 8mg/kg bw seems to be efficient
[51]. Evaluation of melarsomine dihydrochloride at a dose
of 0.2mg/kg bw could also be evaluated (Frans Van Gool,
personal communication).
3.1.3. Strategies for the Use of Trypanocides. It is important
to determine a strategy and the objectives of a treatment,
whichever trypanocide is used. Indeed, in most of the highly
enzootic situations, when the infection is not lethal, such
as T. evansi in bovines, the treatment does not necessarily
aim to completely eliminate the parasite from the animal.
In practical terms, a “mild treatment” (3.5mg/kg bw DA,
e.g.) might be sufficient to kill the majority of parasites,
ensure clinical improvement, and induce the release of a
large amount of parasite antigens to enhance the host’s
immune response. Animals that are treated in this way,
but remain infected, can cope with the infection because
they develop an adapted immune response. This leads to
the status of subclinical infection or healthy carrying. From
the clinical point of view, farmers may think that such
treatment is curative. Maintaining an efficient immune status
is especially important for gestating animals in an enzootic
situation. However, it is important to emphasise that low
dose treatments potentially enhance the development of
chemoresistance.
In bovines, if the objective is to kill all parasites (to clear
a farm from infection or prior to export, or for introducing
an animal into a noninfected farm, etc.), a higher dose of
DA or other chemicals should be used, such as 7mg/kg DA
bw (in the absence of chemoresistance), or 1mg/kg bw IMC,
or 0.5–0.75mg/kg bw of melarsomine dihydrochloride. As
previouslymentioned, in dogs, a strategy of serial lowdoses of
DA injections (3.5mg/kg) could be attempted when sources
of infection are out of control.
When the infection threat is lethal, such as T. evansi in
horses and dogs, a different strategy is generally preferred,
namely, to kill all parasites, as far as possible. The objective in
this case is to achieve fully curative or “sterilizing” treatment,
which requires the use of (i) curative drugs, such as DA
7mg/kg bw (obviously with a high probability of treatment
failure) ormelarsomine dihydrochloride 0.5mg/kg bw; or (ii)
chemoprophylactic drugs, such as quinapyramine sulfate and
chloride 8mg/kg. However, in the case of an invasion of the
nervous system, none of these drugs have yet been proven to
be efficient.
In horses, irrespective of the source of infection (from an
inside extravascular focus in a carrier or from mechanical
vectors that bring parasites from neighbouring infected
hosts), the only option is to treat with quinapyramine sulfate
and chloride at 8mg/kg bw to protect the blood from parasite
invasion. However, if the parasites reach the nervous system,
the disease is always fatal.
3.2. Preventing Infection. In addition to parasite prevention
and control, vector control, or more generally, preventing
infection is an important part of disease control, especially
for highly susceptible species, such as horses and dogs.
3.2.1. Vector Control. In the case of tsetse-transmitted try-
panosomes in Africa, vector control is quite effective at
reducing the trypanosome pressure. The cyclical vectors can
be specifically targeted using insecticide impregnated screens
and insect sterilisation techniques can be used in a limited
livestock breeding area [52].
Conversely, the control of mechanical vectors is not easy
because of the diversity of tabanid species in a given area,
their high mobility and prolificacy. In addition, the larval
stages of tabanids are generally spread over a wide area
and different species colonise various landscapes [53]. The
ecological control of one species might help the development
of another! Consequently, the ecological control of tabanids
is not usually an option.
Tabanid control using insecticide sprays was proven
to be efficient in small closed deforested areas in French
Guyana [54]. However, even in this case, tabanid infestation
reappeared 2-3 years after the end of the control campaign
[23]. When tabanid control is carried out in an open area,
it is not sustainable because tabanids move in from the
surrounding areas to fill the ecological gap created by the con-
trol campaign. Implementation of tabanid control is rarely
attempted because it is costly, unsatisfactory, unsustainable,
and does not provide 100%cover from infection.Nonetheless,
the control methods are described briefly below.
Stomoxys species differ from tabanids in that they develop
within the livestock area or the farm and are closely related
to the farming systems [53]. Stomoxys population control
can be achieved through management methods (see descrip-
tion below). However, sustainable control using mechanical
vectors is not possible because of their high mobility and
prolificacy. Indeed, an adult female tabanid or Stomoxys
may lay 100–200 eggs, 4-5 times in her lifetime. Therefore,
total egg production ranges from 400 to 1000 eggs [53]. By
comparison, a female tsetse fly produces one larva at a time,
approximately 10 times, thus producing 10 flies in her lifetime.
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Figure 3: Nzi trap. A universal trap able to catch tsetse flies,
tabanids, and Stomoxys, especially efficient for large size tabanids.
These are known as the “R” and “K” reproduction strategies,
respectively [55].
Mechanical vectors use the “R” strategy. Their extreme
prolificacy means that if only 2% of the eggs reach the adult
stage, the tabanid population remains stable [53]. Hence, if
more that 2% of eggs reach the adult stage, the populationwill
increase. In order to control tabanid populations successfully,
egg development must be kept below 2%.
The control of surra’s vector populations can be attempted
using traps and/or impregnated screens or using insecticides
on livestock. The most efficient traps for mechanical vectors
are theNzi (Figure 3) and theVavoua trap (Figure 4) [56, 57].
The Nzi trap can catch large tabanid species and Stomoxys,
while the Vavoua trap catches small tabanid species, such as
Chrysops (deer flies) and Stomoxys [58]. However, so far, these
traps have been used to study insects and monitor control
campaigns rather than for actual insect control. Spraying
insecticides, such as deltamethrin on cattle, is efficient for
controlling mechanical vectors [54, 59, 60]. However, the
effect is relatively short-lived, which makes efficient control
costly. The use of targets or impregnated screens, like those
used in Africa against tsetse flies, was not evaluated for the
control ofmechanical vectors. It is an attractive alternative for
the targeted control of biting insects. One of the traditional
methods for controlling biting insects is the use of smoke
released by slow fire (Figure 5). The smoke repels the insects.
However, because it only covers a limited protected area, the
animals in this area reduce their food intake [23]. Mosquito
nets can be used to protect animals, though this is rare
because of the expense. However, individual use does occur,
such as for horses (Figure 6). It is possible to adapt fly-proof
corals or stables for groups of animals, for example, cattle
(Figure 7). Insecticide impregnation of mosquito nets is an
alternative integrated method of control, which can help
reduce biting insects/vector populations.
In Latin America, the vampire bat can act as vector, host,
and reservoir of T. evansi. Consequently, vampire bat control
is an integral part of surra control. The “Japanese net” can be
used to catch vampire bats. It can also be used as a screen
to protect livestock. In this case, it should be set up at night
to create a screen between the bat colony refuge (forest area)
and the livestock farm. Alternatively, the Japanese net can
Figure 4: Vavoua trap. A trap designed for tsetse flies, especially
efficient for Chrysops and Stomoxys.
Figure 5: Smoke released to protect horses from biting flies, Surat
Thani, Thailand.
be used to catch a few bat specimens, which are then used
to kill the colony. Captured animals are coated with drops
of anticoagulant that contains an excipient, such as lanolin,
before they are released. Once the animal has returned to the
colony, it spreads the chemical to the whole colony by licking
and contact. An anticoagulant, such as chlorophacinone, kills
the bats within a few days [23, 61].
3.2.2. OtherMethods to Prevent Infection. In situations where
it is difficult to control the biting insect populations, it may be
easier to control transmission, though not with 100% efficacy.
Tabanids are naturally persistent feeders [62] and they do not
leave one animal to bite another if the latter is more than
50 metres away. Therefore, 200m is considered to be a safe
distance for mechanical transmission by biting insects [62–
64].
However, separating bovines from equines is highly
recommended to avoid the transmission of T. evansi from a
buffalo or cattle reservoir to highly sensitive horses. To avoid
any risk of transmission (even that of occasional contact with
animals that have escaped), it is advisable to breed cattle and
horses in completely different areas that are at least several
kilometres apart.
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Figure 6: Mosquito net system on a stable to protect a horse against
biting flies in an area of high infestation, Ratacha Buri, Thailand.
Figure 7: Fly proof system with mosquito net for cattle stable
(Nakhon Sawan, Thailand).
The case of carnivores is quite unusual. Carnivores may
be infected when they eat the bones, flesh, or blood of an
infected animal that has only just died. Rodents, which are
omnivorous, may become infected like carnivores. T. evansi
can be transmitted via oral infection as demonstrated in a trial
in which per-oral blood was given to rats and mice [26, 27].
To avoid such infections, the dead animals’ carcasses should
be eliminated as soon as possible and dogs, especially stray
dogs, should be contained around slaughterhouses, as well as
on livestock farms in general.
In addition to per-oral contamination, dogs may also
contract the infection from biting flies, especially the dog
fly, Stomoxys, when they live in the vicinity of reservoir
animals, such as cattle and horses. As mentioned above, host
species must be well separated to avoid the interspecific host
circulation of parasites.
3.2.3. Preventing Introduction into a Noninfected Area. As
was recently observed in Spain and France [65], healthy or
inapparent carriers may be responsible for introducing the
parasite from infected to noninfected areas. A number of
measures, that are currently being studied, could be applied
in order to avoid this type of introduction. The detection of
carriers is based on laboratory detection according to the
guide of methods recommended by the World Organisa-
tion for Animal Health (WOAH) in its terrestrial manual,
Chapter 2.1.17. It is available online at the following address:
(http://www.oie.int/fileadmin/Home/fr/Health standards/
tahm/2.01.17 TRYPANO SURRA.pdf)
Diagnosis techniques for surra are based on four types of
examination (referred to below as “surra tests”): microscopic
examination, DNA detection by PCR, CATT/T. evansi and
ELISA T. evansi (detailed protocols are available at the above
link).
For the international trading of animals, the following
guidelines could help avoid the introduction of infected
animals into noninfected areas.
(i) Two quarantines should be applied for the interna-
tional trade of equines and/or camelids (which could
be extended to any mammal) from an infected coun-
try to a noninfected country: a 4-week quarantine at
the exporting farm and a 4-week quarantine at the
importing farm.
(ii) To qualify for trading, an animal should originate
from a noninfected farm in a nonsuspect area, and
be negative to surra tests twice at a 3-4 week interval
during each of the quarantines.
(iii) A farm is considered to be in a nonsuspect area if there
have been no reports of surra in the previous 3 years
within a 30 km radius of the farm.
(iv ) A noninfected farm is a farm located in a nonsuspect
area, which only permits the introduction of animals
that are negative to the surra tests and that originate
from noninfected farms located in a nonsuspect area.
To obtain the status of noninfected farm, all mammal
species on the farm must be negative to surra tests
twice at a 3-month interval. To maintain the status
of noninfected farm, all mammal species on the farm
must be negative to surra tests when tested every 10–
12 months.
If thesemeasures were adopted, theywould considerably help
to control the circulation of animals infected with T. evansi.
4. Epidemiology
Surra is a disease that can show the following: (i) various
symptoms in a given host (from subclinical evolution to
abortion or death, with or without vascular, nervous, or
genital signs); (ii) various symptoms fromone host to another
(mostly lethal in horses, acute or chronic in camels, variable
in bovines and buffaloes, acute in dogs, and generally mild
but sometimes acute in pigs, sheep, and goats, etc.); as well
as (iii) various aspects in different places (surra in buffaloes
and cattle is virtually absent in Latin American, although it
is a major constraint in South East Asia). The epidemiology
of a disease depends on the characteristics of a pathogen,
its hosts, reservoir, and vectors and their environment and
interrelations. Consequently, in the peculiar case of surra,
which is a multispecies disease, it can exhibit highly variable
characteristics because of its highly complex epidemiology.
The study of the epidemiology of surra requires var-
ious specific diagnostic tools. Detailed procedures are
available from the World Animal Health Organisation
(WAHO/OIE) website, terrestrial manual, under Chapter
2.1.17 Trypanosoma evansi infection (surra), as indicated
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above. For this reason, we only present a summary of
the techniques and their characteristics, as required for a
comprehensive description of surra’s epidemiology.
4.1. Diagnostic Tools. As described above, clinical signs are
only indicative of surra.The definitive diagnosis involves lab-
oratory analysis, either by using parasitological or molecular
tools to demonstrate the presence of the infection or by using
serological tools to prove immune contact.
Parasitological examinations are usually conducted using
blood, although other biological materials can be used, such
as cerebrospinal fluid (in the case on nervous signs), joint
fluid, or lymph node fluid. Microscopic observation (×400–
500) of fresh blood is easy to carry out. However, it is of
limited sensitivity because it detects parasites when para-
sitaemia is above 105 trypanosomes/mLof blood. Enrichment
methods are widely used, namely, Hematocrit Centrifuge
Technique (HCT) [66] or dark ground Buffy Coat Method
(BCM) [67]. They increase the sensitivity of the test down
to 100–200 trypanosomes/mL. If high sensitivity is required,
inoculating laboratory rodents can reveal infection. It low-
ers the minimum level of parasitaemia detected to 20–
50 parasites/mL.
In addition, molecular evidence of T. evansi DNA can
be tested using PCR with a number of primers specific for
the subgenus Trypanozoon, or to species levels [68]. Despite
being relatively expensive and technical, PCR is generally
used to improve the sensitivity of the detection. Comparative
studies have led to the recommendation of TBR primers [69]
as the most sensitive primers for detecting T. evansi [70], and
the Phenol-Chloroform method [71] as the most sensitive
DNApreparationmethod [72]. A combination of thesemeth-
ods provided a sensitivity of around 5–10 trypanosomes/mL
of blood (or other fluid).
In addition to the use of parasitological or molecular
tools for detecting T. evansi infection, serological tests that
prove the immune contact between the host and the parasite
are quite useful. They can be applied to investigations at
herd or population level (prevalence or incidence studies),
follow-up (seasonal or interannual variations), or control
method assessment (trypanocide treatment or vector con-
trol). The most common tools are the Card Agglutination
Test for T. evansi (CATT/T. evansi) [73] and the ELISA T.
evansi [74, 75]. CATT can detect immunoglobulin M and,
therefore, early infections, whereas ELISA is generally used
to detect immunoglobulin G, that is, established infections.
Consequently, these tests are complementary and work well
together. ELISA T. evansi is quite robust, regardless of the
host species. It provides the same range of sensitivity and
specificity (90–95%) in the various host species investigated,
for example, camels, cattle, buffalo, and horses.The sensitivity
of CATT T. evansi varies from one host to another. CATT
seems highly sensitive in camels and horses, although it has a
very low sensitivity in cattle (12%), even under experimental
conditions [41].
4.2. Africa and the Middle East. In Africa and the Middle
East, T. evansi is responsible for an acute or chronic disease
principally found in camels, horses, and dogs in the north of
the tsetse belt [76]. In camels kept close to the tsetse belt, some
cases of T. brucei brucei have been recorded. T. congolense
infections are fatal to camels. Therefore, camels should not
be allowed to enter the tsetse belt unless they are permanently
protected with the use of chemicals. Consequently, T. evansi
is not found in the tsetse belt. Thus, the epidemiology of
surra in Africa is mainly governed by camel infections. The
latter are seasonal because the vectors’ activity is seasonal and
the disease is expressed seasonally, at times when animals
are exposed to stress from overwork, food shortages, and/or
insufficient or poor quality water [77]. For example, in Mau-
ritania, by using CATT and IFAT blood smears, it was shown
thatT. evansi infectionwaswidespread in the country, with an
overall prevalence of 1.3% by parasitological detection. This
level reached 18.4% to 31% with serological tests [78]. Other
host species, such as goats, may be infected occasionally and
could act as a reservoir. However, their impact was never
demonstrated [79]. In cattle, especially transhumant herds,
that spend part of the year within the tsetse belt and the rest
of the year in the northern region, it is difficult to distinguish
between infections due to T. brucei and T. evansi. The latter is
probably rare because, even under experimental conditions,
the infection of African cattle by T. evansi proved to be
difficult as a consequence of their low susceptibility [80].
The transmission of T. evansi can only occur if the “donor
host” exhibits high parasitaemia. This is because T. evansi is
mechanically transmitted by biting insects (due to the very
small amount of blood transferred from one host to another).
In Africa, only camels and horses may be a source for this
type of transmission.Hosts that have a low susceptibility, such
as cattle and goats, are likely to constitute dead ends, even
if they may occasionally be infected when close to infected
camels or horses. Finally, given that camels and horse cannot
enter the tsetse belt without being at risk fromNagana, which
is fatal to both hosts, and because other hosts that could be
infected by T. evansi do not exhibit sufficient parasitaemia
to play an important role in surra’s epidemiology, there is
a reciprocal exclusion of Nagana in the southern territory
(among tsetse flies, livestock, and wild animals) and surra,
which is restricted to the northern region (amongmechanical
vectors and camels).
In the Middle East and towards Asia, the geographical
distribution of T. evansi is closely related to that of camels
and dromedaries [15]. However, no difference was observed
in terms of the pathogenic effects of the parasite in this host
species, which like horses are highly sensitive to the infection.
Overall, surra affects mainly camels with acute and
chronic infections that cause death. Infection is contracted
during the rainy season when there is a peak level of biting
insects. Camels constitute the main reservoir of T. evansi in
this region.
4.3. Latin America. In Latin America, the disease is called
Mal de Caderas (Brazil),Murrina (Central America), or Der-
rengadera (Venezuela) (Wells 1989). T. evansi is principally
pathogenic in horses and induces outbreaks with very high
morbidity and mortality. It also affects buffaloes (Bubalus
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bubalis). In Venezuela, although infection in buffaloes by
T. evansi showed significant signs such as spleen, liver, and
glandular enlargement, together with lymphoproliferation,
the economic impact of infections has not been assessed
[81]. Trypanosoma evansi regularly affects dogs (especially
hunting dogs) and even cats. In both cases, the disease is
usually fatal. In Latin American cattle, sheep, goats, and pigs,
T. evansi is generally considered as a low pathogenic agent. It
is regularly found in awide range of wild reservoirs, including
capybaras (Hydrochoerus hydrochaeris), which is the most
well known, together with white tail deer (Odocoileus vir-
ginianus chiriquensis), brocket deer (Mazama satorii), coati
(Nasua nasua), vampire bats (Desmodus rotundus), wild pigs
(Tayassu tajacu), Guinea pig (Cavia porcellus), wild dog
(Canis azarae), and ocelot (Felis pardalis). Llamas are also
receptive to the disease and infected animals have been
found, although little is known about its impact [23]. There
is no obvious link between wild and domestic fauna. In
some places, the prevalence of infection may be very high
in capybara and coati, while it remains low in horses [82].
In French Guyana, the parasite has never been found in
livestock, including horses, but it was first described in 1995
in a hunting dog, which was probably infected by wild fauna
whenhunting in the forest [23]. Surra remains amajor disease
in Latin America, especially because horses (sensitive host)
are used for herding cattle (reservoir) in extensive conditions
in Venezuela and Brazil, for example.
Overall in Latin America, surra is predominantly a
disease that affects horses. However, a large range of wild
and domestic mammals can act as a reservoir. In most cases,
farmers use chemoprophylactic drugs regularly to protect
horses against T. evansi (isometamidium or quinapyramine).
This treatment ensures that they stay alive and efficient for
work. As a result, two groups of livestock are kept in close
contact: a low susceptible reservoir made up of bovines
and a highly susceptible host made up of horses under
chemoprophylaxis.
4.4. Asia. In Asia, the geographical distribution ofT. evansi is
spreading steadily. It is present in large areas in India, China,
and Russia [83, 84]. It is sometimes difficult to distinguish it
from T. equiperdum [85]. It is present in Camelus bactrianus
and horses in Mongolia, with low prevalence. It is more
frequent in Uzbekistan and Kazakhstan. In South East Asia,
it affects principally horses, dogs, and buffaloes (Bubalus
bubalis), as well as cattle, pigs, and deer. It has been described
in tigers in India [21], as well as in Thai elephants [86].
In the water buffalo, T. evansi causes production losses,
abortion, and early calf mortality. It also has immuno-
suppressing effects, which decrease the efficacy of some vac-
cines (especially of the vaccine for hemorrhagic septicaemia).
In bovines, its pathogenicity in Asia is superior to that of
African and American strains. We do not know whether
the difference is due to the presence of more sensitive dairy
breeds in Asia, or if the local populations ofT. evansi aremore
pathogenic to cattle, or both.
In India, surra is present all over the country in various
hosts, such as cattle, buffaloes, camels, donkeys, dogs, and
horses [87]. A recent survey carried out on horses showed
a maximum seroprevalence (20%) for T. evansi infection in
Uttar Pradesh. There was an overall seroprevalence of 11% in
north and north-western regions of India, which confirmed
that surra is endemic in equids in these areas [88].
In Thailand, a study on seroprevalence carried out in
dairy cattle demonstrated the presence of the parasite in
most parts of the country. The mean seroprevalence was 8%,
ranging from 0 to 100% at farm level and 25% of dairy cattle
are exposed to the infection [89]. Similar studies conducted
on buffaloes and beef cattle showed seroprevalence of 10–
12% (Desquesnes, unpublished data). Molecular evidence of
T. evansi was also obtained in various wild rodents [90, 91].
However, their role in the epidemiology of the disease is
not known. In horses, several outbreaks are recorded every
year and are frequently fatal. Indeed, serological studies show
very low evidence of positive animals; in other words, there
are few survivors after the outbreaks [44, 92]. Elephants are
affected by surra. Cases are reported rarely but regularly.
They may be fatal or develop into a chronic or subclinical
evolution, depending on the case [50]. Surra outbreaks occur
seasonally and are generally linked to the activity of biting
flies. In Northeast Thailand, seasonal occurrence is observed
at the beginning of the rainy season (June-July) and in winter
(October-November) [93]. Bovines (cattle and buffaloes)
exhibit moderate signs and impact. However, they constitute
a permanent threat to themselves and horses, which may die
or survive under permanent chemoprophylaxis.
In the Philippines, over the past decade, the number
and severity of surra outbreaks have increased dramatically.
The highest mortality is in horses, carabao (Asian water
buffalo), and cattle. As a result, the Philippine government
now regards surra as the second most important livestock
disease [94]. Indeed, surra has emerged as themost important
cause of livestock mortality in the Philippines, prompting the
government to implement a national control strategy.
In Indonesia, the disease appears in sporadic outbreaks,
mainly in horses, buffaloes, cattle, and dogs, although it is also
present in sheep, goats, pigs, and wild animals [94–96]. The
parasite was found throughout most of the archipelago. Its
regular occurrence suggests the existence of enzootic stability,
including an efficient reservoir [95, 96]. However, an update
of information is required.
In Vietnam, Laos, and Cambodia, the disease occurred
especially in horses, buffaloes, and cattle, although it was
given little attention. Serological surveys demonstrated the
presence of infection in all the areas investigated. Limited
means are available for carrying out studies on surra since
priority is given to other diseases in these countries. Hence,
the situation is not well documented.
Similarly in Malaysia, although the disease has been
known for years, a national survey has not yet been organised
to evaluate its impact. Surra is regularly detected in horses,
deer, pigs, buffaloes, cattle and, rarely, in dogs. It was also
reported in Sumatran rhinoceroses [97]. In Malaysia, a
seroprevalence survey carried out in 2012, for dourine in
horses usingCFTdid not reveal its presence [98]. Diagnosis is
routinely carried out using amouse inoculation test and buffy
coat examination. Thin blood smears are also conducted in
regional laboratories. Prophylactic treatment is administered
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to livestock in high-risk areas where cattle and buffaloes live
in close proximity to pigs or horses [99, 100]. In domesti-
cated deer, the infection is observed regularly. Fulminating
parasitaemia is detected when the animals become weak
and recumbent. Nervous symptoms are not clearly evident;
however, fatality ismost often observed during the outbreaks.
Trypanosoma evansi is not present in Australia, but it may
spread eastward from Indonesia to Papua New Guinea and
then Australia [101].
Overall in Asia, surra is mainly a disease of horses and
buffaloes. It benefits from a large reservoir made up of
buffaloes, cattle, deer, and possibly wild animals, such as
deer and rodents. On cattle farms, little attention is given
to the disease, even though it may cause serious economic
losses, via abortion, weight loss, and immunosuppressive
effects. An evaluation of the economic impact is needed
to determine whether it would be profitable to eliminate
the infection. Horse breeders generally avoid close contact
between buffaloes and horses to avoid the risk of infection,
which is generally fatal and uncontrollable because of the
limited efficacy of trypanocides [34, 36]. When horses are
bred in the same area as cattle or buffaloes, farmers regularly
use chemoprophylactic drugs to protect horses against T.
evansi (isometamidium or quinapyramine). Nonetheless, T.
evansi remains a permanent threat to livestock throughout
South-East Asia, with a decreasing gradient of impact for
horses, buffaloes, dogs, cattle, deer, pigs, sheep, and goats.
5. Impact
There is limited information on the impact of surra among
livestock in endemic countries, particularly (i) its impact
on host population dynamics and demographics, (ii) the
economic losses due to the disease, and (iii) social impact
on animal owners. It is common knowledge that surra is an
economically important disease, which causes highmortality,
low milk and meat production, poor carcass quality, reduced
reproductive performance, decreased draught power and
manure production, and immunosuppression in livestock
[94, 102–105]. Yet, only few studies have quantified the
economic value of the losses (including expenditure on diag-
nosis, treatment, and replacement of lost animals) for limited
animal species and for limited locations. Little information is
available on the financial benefits of treating/controlling surra
in infected animal populations.
The impact of surra on host population dynamics and
reproduction has been extensively investigated for buffaloes
in the southern Philippines [106]. Surra has a significant neg-
ative impact on buffalo populations, causing high mortality
and reproductive losses. In particular, in surra endemic areas,
buffalo herds have fewer calves, 50% lower calving rate and
higher removal rates (including adult mortality and early calf
deaths), than buffaloes in areas where surra is not detected.
Higher mortality has been recorded amongst young buffalo
cows aged 2–8 years old in surra-endemic areas compared to
surra-free villages (9.1% versus 0.1% mortality, resp.). Given
the decrease in the buffalo population in surra-endemic
areas, replacement buffaloes are regularly imported because
they provide essential draught power for farm operations
[106, 107]. This impact may also be true for other animal
species that are susceptible to T. evansi. However, further
investigations are required to validate the impact of surra on
other hosts.
The low calving performance among buffaloes in Min-
danao (in the Philippines) is closely linked to abortion and
infertility [107]. In Thailand, abortions and reproductive
failure due to surra have also been demonstrated in buffaloes
[108], cattle [104, 109, 110], camels [111], and horses [34, 112].
The death of buffalo cows during their most productive
phase reduces their life expectancy (by almost half) and
has a major impact on farmers. Females at this age are
highly valued for draught power and as breeding animals
for replacement or sale (to provide additional income) or
home consumption. Surra has been proven to causemortality
in buffalo after experimental [113] or natural infection [83,
102, 114, 115].Whilst mortalities in draught buffalo caused by
surra could be partly associated with stress due to overwork,
other factors such asmalnutrition, concurrent infections, and
adverse climatic conditions may contribute to the animals’
reduced resistance and higher susceptibility to the disease
[102, 115]. Surra is also lethal in other livestock species, such
as horses [116–118], camels [111, 119], guanaco [120], cattle
[86, 121], goats [122–124], sheep [125], and even pigs [126].
Indeed, in the Philippines, serious outbreaks of surra with
highmortality rates have occurred in horses, buffaloes, cattle,
small ruminants, and pigs [94, 102, 106, 127].
The financial losses due to surra are high, but treat-
ment is cost effective. Recent estimates using a bioeconomic
infectious disease model suggest that a typical village in the
Philippines with livestock (80 buffaloes, 40 cattle, 200 pigs,
150 goats/sheep, and 15 horses), affected with moderate to
severe surra, can lose as much as US $158,000 every year.
However, it was demonstrated that the same village could
earn the same amount of money if treatment was used
[128]. The model was developed using a vast amount of data
from a 4-year field survey in Mindanao, in the Philippines,
where surra is highly endemic. By comparison, the previous
estimate of losses due to surra in the Philippines was only US
$0.1 million yearly nationwide [102]. The previous estimate
was only based on the limited mortality data submitted to
the government [102], whilst the current data were based
on losses due to mortality, low reproduction, diagnosis,
treatment costs, and replacement costs [128]. However, the
present monetary estimates of losses due to surra may still
be an underestimation because some factors were not taken
into account: losses from weight loss, carcass quality, milk
production, draught output, and reduction in selling price.
In Mindanao, the market price for T. evansi-infected animals
is very low (30–50% lower). The high financial losses caused
by T. evansi infection in livestock in endemic areas have a
great social impact on poor farmers and their familieswho are
dependent on their livestock for farm activities and income.
The need to import replacement stock from other sources is
also an additional financial burden for marginal low-income
farmers.
Financial losses due to surra can be avoided by adopting
an effective control approach that includes an effective control
strategy. In surra-endemic areas in Pantanal, Brazil, where the
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cattle industry is significant and horses are used for herding
livestock, year-long monitoring and treatment of horses
with diminazene aceturate have been shown to be the most
economical treatment option, with a total net benefit of more
than US $2 million per year [116]. Nevertheless, this strategy
assumed that the drug is 100% effective against T. evansi,
which is unlikely to be the case, particularly in areas where
drug resistance exists. Similarly, in the Philippines, targeted
treatment of all animals infected with surra throughout
the year using a highly effective drug (e.g., melarsomine
dihydrochloride) is the most beneficial treatment strategy.
Biannual mass treatment of all livestock species in a village
is also financially viable but may result in drug resistance
amongst T. evansi isolates [128].
As a conclusion on the epidemiology, impact, and control
of surra, a regular and sustained effective surveillance system
must be carried out to monitor and assess the efficacy
of treatment strategy, and support the control efforts. The
success of any surveillance and control activities for surra
is depending, amongst others, on (i) financial and resources
allocation, (ii) support from the stakeholders (including local
government officials), (iii) commitment of the surveillance
and technical staff, and (iv) effective reporting system and
close cooperation with the farmers. Animal owners should
be properly educated on surra (e.g., impact, biology, and
clinical signs), be empowered in monitoring their animals
for any evidence of the disease, and be aware on whom and
how to report to concerned authorities for confirmation and
treatment. Regular monitoring and immediate treatment of
animals with surra with an effective trypanocide were shown
to be economically beneficial [128]. Random sampling of
livestock using a combination of appropriate diagnostic tests
(serological and parasitological or molecular) must also be
regularly carried out in endemic locations to assess efficacy
of the control program and detect potential asymptomatic
carriers. Subclinical surra may occur in healthy animals (e.g.,
buffaloes, cattle) [106, 129]); they are a real infection threat (as
potential sources of the parasite) to other animals, including
highly susceptible ones such as horses, camels, and dogs
[130, 131]. Therefore, identification and subsequent treatment
of subclinically infected livestock are significant to any efforts
to control surra amongst livestock.
6. Zoonotic Aspects
Trypanosoma evansi is morphologically indistinguishable
from the bloodstream form of Trypanosoma brucei spp., the
causative agents of human sleeping sickness (African Human
Trypanosomosis, HAT), that is, T. b. rhodesiense and T. b.
gambiense and the pathogen of animal Nagana, T. b. brucei.
However, the host range of T. evansi is restricted to nonhu-
man animals because of its susceptibility to cytolysis by the
trypanolytic factor in normal human serum (NHS). The try-
panolytic factor was first found as a consistent component of
high density lipoprotein. A later subfractional study showed
that this component was apolipoprotein L-1 (ApoL-1) [132,
133]. The main components involved in NHS-mediated try-
panolysis are the primate-specific apolipoprotein L-I (apoL1)
and haptoglobin-related protein (Hpr), which are associated
with aminor subfraction ofHDLs and an IgM/apolipoprotein
A-I (apoA1) complex, respectively, termed trypanosome lytic
factor (TLF) 1 and TLF2. The TLF1-Hpr-haemoglobin (Hb)
complex binds to the trypanosome haptoglobin (Hp)-Hb
receptor, which triggers efficient uptake of TLF1 and subse-
quent trypanosome lysis [134]. The trypanolytic activity of
ApoL-1 is caused by the formation of an ionic pore in an acid
pH environment [135]. This requires the translocation of the
molecular membrane into a lysosomemembrane, possibly by
the haptoglobin-hemoglobin (Hp-Hb) receptor [136]. Apo L-
1 are human apolipoproteins considered as the trypanolytic
factor present in NHS. They provide innate protection to
humans from infection by African trypanosomes, such as T.
evansi, T. b. brucei, and others, with the exception of T. brucei
rhodesiense and T. b. gambiense, which developed resistance
mechanisms [137].Thus, T. evansi has long been considered a
nonhuman infective species similar to T. b. brucei. However,
in 2005, a human case of trypanosomosis caused by T. evansi
was reported in a farmer from the Chandrapur district in the
Maharashtra State, India [138–140].
In this case, the man had fluctuating trypanosome para-
sitaemia associated with febrile episodes for several months.
In the absence of central nervous system invasion, the patient
has been treated successfully with suramin. Contamination
by contact of a wound with infected animal blood was
suspected [140].
The infection was puzzling because the trypanosomes
isolated from the patient were found to be typical T. evansi
based on the analysis usingmolecular biology [141]. However,
later it was demonstrated that the infection was due to the
frameshift mutations in both Apo L-1 alleles in the patient
[142]. This led to an unexpected termination of protein
translation by internal stop codons [142], which resulted in a
total absence of Apo L-1.Without Apo L-1, the patient lost his
protection against T. evansi and the infection thus developed
human surra [140]. An investigation is urgently required on
the distribution of mutated Apo L-1 alleles in the populations
and the exposure of the population to T. evansi in prevalent
areas in order to determine the potential of T. evansi to infect
humans.
A serologic screening was carried out in the surrounding
area near the first human case. Serum or blood from 1,806
people from the patient’s village of origin was tested with
the CATT/T. evansi. The results showed that 4.5 to 22.7%
were positive samples (with serum or blood, resp.). No
trypanosome was detected in the blood of 60 people that
were highly positive. These results suggest that the human
population is frequently exposed to T. evansi [143]. The
specificity of the CATT has not been investigated in humans
in Asia. Thus, further research is required.
Given the wide distribution of this parasite in developing
countries, a large part of the population is at risk from infec-
tion, either by direct contact (percutaneous infection), or
per-oral or, more likely, via bites from blood-sucking insects
that have previously fed on infected animals. Thus, although
there are no reports on the prevalence of mutated Apo L-1
alleles in the populations, people are still at risk, particularly
immunosuppressed individuals living in the regions where T.
evansi is endemic.
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In fact, there were some suspected cases of human
trypanosomosis caused by T. evansi. The earliest case was
reported by Gill [2], in a scientist infected while pipetting
infected blood. The symptoms were insomnia, tachycardia,
enlargement of liver, spleen, and lymph nodes, and loss of
recent memory. In this case, nervous invasion was likely and
was successfully treated with atoxyl (p-aminophenylarsenic
acid). More recently, a case was reported on ProMED-mail
in 1999 [144]. The case was not officially published, but
trypanosomes isolated from the patient were confirmed as
T. evansi using PCR (W. Gibson, University of Bristol, UK,
personal communication). A further four cases of suspected
human trypanosomosis caused by T. evansi infection were
reported in India with one mortality [145, 146]. However,
no confirmatory reports have been obtained until now.
Currently, a human infection by T. evansi was also reported
from Egypt although no details were provided regarding the
status of the gene of Apo L-1 in the patient [147].
The resistance to ApoL-1 of pathogens of African sleeping
sickness was demonstrated by at least two different strategies
with the neutralization by SRA in the case of T. b. rhodesiense
[148] or the limited sublethal uptake of ApoL-1 in the case of
T. b. gambiense [149]. Actually, it was recently demonstrated
that the loss of the Hp-Hb receptor reduced the susceptibility
of trypanosomes to TLF-1, and to a lower extent to TLF-
2, suggesting that both toxins can be taken up via the
Hp-Hb receptor, but those alternative pathways exist [150].
Although SRA is absent in T. evansi, a pseudo gene called
SRABC has been confirmed [151]. Given the fact that T.
evansi is directly transmitted by blood sucking insects with
no development stages (life cycle) in the vector (like those
found in T. brucei), the horizontal gene transfer of SRA
observed in T. b. rhodesiense is highly unlikely. However,
tolerance to NHS among the T. evansi stocks was reported
[152]. Unfortunately, it was noted that the tolerance to these
stocks could be enhanced by continued exposure to NHS
[152]. Similar results were found in T. b. brucei, genetically
very close to T. evansi, after 9 months of in vivo selection
withNHS [153]. It was suggested that the reduction of ApoL-1
uptake might be associated with the low level of haptoglobin-
hemoglobin receptor expression [154]. Whether T. evansi
could develop any of the above strategies or others to resist
ApoL-1 lysis remains uncertain.The lack of innate protection
of ApoL-1 in humans or the development of new capacities in
parasites to counter innate immune responses could lead to
the evolution of a major new trypanosome pathogen.
Lastly, although T. evansi is still not considered to be a
zoonosis, it is wise to remain cautious. The same applies to
other trypanosomes, such as Trypanosoma lewisi, which as
yet is considered to be atypical in humans [155].
In addition to these cases, other reports of cases where
humans are infected by Trypanosoma lewisi and T. evansi
[156–158] have led to the creation of a new network to coordi-
nate information and research on atypical human infections
caused by animal trypanosomes (NAHIAT). (The NAHIAT,
Network on Atypical Human Infection by Animal Try-
panosomes, was created in May 2011. It is coordinated by the
Institute of Research for Development (IRD) and the Center
for International Collaboration on Agricultural Research for
Development (CIRAD)with the support of FAO,OIE,WHO,
and a number of international research institutes and univer-
sities. Contacts: Dr. PhilippeTruc<philippe.truc@ird.fr> and
Dr. Marc Desquesnes <marc.desquesnes@cirad.fr>.) In this
new context, further cases of human infections by T. evansi
have already been reported [159].
7. Conclusions and Perspectives
The exact origin of T. evansi has not been fully clarified.
In fact, in reality there may be “several” T. evansi [160].
Nonetheless, most of the parasite’s dominant properties are
well known, with the exception of its particular ability
to induce immunosuppressive effects. This aspect requires
additional investigation, which in turn could provide the
opportunity to further our understanding of infectious par-
asitic immunosuppression.
This brief review of the fundamental knowledge of T.
evansi has provided the opportunity to emphasise the fact
that this parasite has an unlimited geographical distribution.
Its distribution is directly related to its almost unlimited
range of hosts. The same applies to its unlimited range
of potential reservoirs and its unlimited, nonspecific, and
ubiquitous range of potential vectors. Lastly, the loss of some
DNAmaterial has made T. evansi a better parasite, inasmuch
as it is less specific in terms of vector and geographical
distribution! By losing its dependency on tsetse flies, which
are ecologically restricted to a specific area in Africa,T. evansi
has travelled unlimited distances and found vicariant hosts
and the necessary reservoirs and vectors for its successful
expansion. It is important to emphasise that the geographical
expansion of T. evansi is not limited, and recent outbreaks
of surra in Spain and France are of serious concern for the
health authorities. It is important to note that in Europe
and Australia, this restless parasite should be monitored
closely! Similarly, the undocumented situation in Turkey,
Bulgaria, and neighbouring countries, such as Greece, should
be givenmore attention. Surramight well become established
unseen in less susceptible domestic and wild fauna in Europe,
before an outbreak is reported with fatal cases among the
more susceptible domestic hosts. Sanitary measures should
be improved because, as the recent outbreaks in Spain and
France have shown, healthy or inapparent carriers ofT. evansi
can be exported from infected to noninfected areas of the
world. The necessary measures are proposed in this paper.
The main vectors have been identified as Tabanids and
Stomoxys. However, theoretically the vectors are unlimited
and a number of questions have yet to be answered. What
is the relative role of Haematobia sp., which is sometimes
very abundant in some hosts, such as camels and buffaloes?
An even more important question is the following: what is
the potential of Stomoxys sp. for delayed transmission? It
could play a role in interherd transmission, including the link
between domestic and wild animals. If this was the case, it
would determine the framework for controlling the disease
in situations where domestic animals are found in the same
areas as other domestic or wild hosts that potentially act
as a reservoir for the parasite. Determining the capacity of
Haematobia and Stomoxys to transmit T. evansi, as well as
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all the other mechanically transmitted pathogens (bacteria,
viruses, and parasites), at intervals of a few hours or days is a
major challenge for research.The results would influence risk
evaluation and means of controlling the parasite, especially
in the case of new disease emergence in countries previously
free of infection. Other modes of transmission should also be
investigated, such as leeches, ticks, and bugs that may even
act as passive carriers.
It is still unclear why T. evansi is considered to be non-
pathogenic to cattle in Africa and Latin America and yet is
a major pathogen in Asia. The answer may be found in the
genetic make-up of the parasites and/or the cattle themselves.
However, the variability of the effects of surra infection in
a host from the “same” species is a general feature. Highly
variable effects have been recorded in cattle, as well as buffalo,
sheep and even horses and dogs. Infected animals may die
in over 90% of cases or appear perfectly healthy in highly
enzootic conditions. In the field, these variations may well be
related to a complex that includes host and parasite genetics,
epidemiological situation, vector pressure, control measures,
and other sanitary or zootechnical parameters, which could
be seasonal. However, we still do not fully understand the
pathogenicity of T. evansi in Asian cattle and buffalo. It
remains one of the greatestmysteries of this amazing parasite.
However, research in Indonesia and the Philippines has
confirmed that South East Asian isolates of T. evansi are
more pathogenic than African isolates and that isolates of
T. evansi from the Philippines are more pathogenic than
those collected in Indonesia [161, 162]. These results may
partly explain why surra is a much more severe disease in
the Philippines compared to other endemic countries [102,
106, 107, 128]. Our ultimate objective is to help focus control
programmes on high-risk areas by identifying the presence
of these “pathogenic” strains using PCR. Research on the
proteomic characterisation ofT. evansi is aimed at identifying
proteins involved in this pathogenic process.
The basic knowledge on T. evansi suggests that there is
renewed interest in the parasite, which is spreading and has
an economically important impact. This review has stressed
the highly variable characteristics exhibited by a taxon called
Trypanosoma evansi under various circumstances, in various
geographical locations, and in interactions with specifically
and genetically varied hosts, reservoirs, and vectors.The large
range of interactive phenotypic aspects probably reveals a
genetic diversity that should be evaluated via complementary
studies and reviews on the molecular epidemiology of Try-
panosoma evansi in order to help further our understanding
of the parasite’s polymorphic features.
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